Gene · 1601
Papers1,661
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,661
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA-sequencing and genome-wide Mendelian randomisation along with abundant machine learning methods identify a novel B cells signature in gastric cancer. | Discov Oncol | 2025 | 39760915 | PubTator, text mining | PubMed |
| Vacuolar H+-ATPase and Megalin-Mediated Prorenin Uptake: Focus on Elements Beyond the (Pro)Renin Receptor. | J Cell Physiol | 2025 | 39745029 | PubTator, text mining | PubMed |
| Disabled 2 (Dab2) Regulates Tumour Progression in Skin Squamous Cell Carcinoma. | Exp Dermatol | 2024 | 39503168 | PubTator, text mining | PubMed |
| Genetic Markers of Spina Bifida in an Indian Cohort. | J Indian Assoc Pediatr Surg | 2024 | 39479418 | PubTator, text mining | PubMed |
| Condensate remodeling reorganizes innate SS18 in synovial sarcomagenesis. | Oncogenesis | 2024 | 39468035 | PubTator, text mining | PubMed |
| Evaluating the association between placenta DNA methylation and cognitive functions in the offspring. | Transl Psychiatry | 2024 | 39304652 | PubTator, text mining | PubMed |
| Are cities under bright lights more innovative? Evidence from China. | Heliyon | 2024 | 39253158 | PubTator, text mining | PubMed |
| DAB2 + macrophages support FAP + fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer. | Theranostics | 2024 | 39239526 | PubTator, text mining | PubMed |
| ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes. | Endocrinology | 2024 | 39207954 | PubTator, text mining | PubMed |
| Peptidomimetic inhibitors of the VEGF-A165/NRP-1 complex obtained by modification of the C-terminal arginine. | Amino Acids | 2024 | 39181965 | PubTator, text mining | PubMed |
| The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression. | Mol Biol Rep | 2024 | 38822973 | PubTator, text mining | PubMed |
| Dab2 (Disabled-2), an adaptor protein, regulates self-renewal of hair follicle stem cells. | Commun Biol | 2024 | 38702433 | PubTator, text mining | PubMed |
| Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins. | J Pharmacokinet Pharmacodyn | 2024 | 38691205 | PubTator, text mining | PubMed |
| Decoding dynamic miRNA:ceRNA interactions unveils therapeutic insights and targets across predominant cancer landscapes. | BioData Min | 2024 | 38627780 | PubTator, text mining | PubMed |
| Identification of the role of DAB2 and CXCL8 in uterine spiral artery remodeling in early-onset preeclampsia. | Cell Mol Life Sci | 2024 | 38613672 | PubTator, text mining | PubMed |
| Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution. | Cell Biochem Biophys | 2024 | 38594547 | PubTator, text mining | PubMed |
| Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38502243 | PubTator, text mining | PubMed |
| STAT3-mediated up-regulation of DAB2 via SRC-YAP1 signaling axis promotes Helicobacter pylori-driven gastric tumorigenesis. | Biomark Res | 2024 | 38481347 | PubTator, text mining | PubMed |
| AMPK-upregulated microRNA-708 plays as a suppressor of cellular senescence and aging via downregulating disabled-2 and mTORC1 activation. | MedComm (2020) | 2024 | 38463393 | PubTator, text mining | PubMed |
| The scaffold protein AXIN1: gene ontology, signal network, and physiological function. | Cell Commun Signal | 2024 | 38291457 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1601/papers?page=3